Combination drug therapy shrinks pancreatic tumors in mice

A combination of two drugs appears to be effective at shrinking pancreatic cancers in laboratory mice Pancreatic cancer is one of the most deadly of all human cancers, and its incidence is increasing. A combination of two drugs, one already approved by the Food and Drug Administration, appears to be effective at shrinking pancreatic cancers in laboratory mice, according to a new study by researchers at the Stanford University School of Medicine. The drugs, which affect the structure and fu...
More